- Home
- AGAE vs CCEL Comparison
AGAE vs CCEL Comparison
Compare AGAE & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGAE
- CCEL
- Stock Information
- Founded
- AGAE 2017
- CCEL 1989
- Country
- AGAE United States
- CCEL United States
- Employees
- AGAE N/A
- CCEL N/A
- Industry
- AGAE Cable & Other Pay Television Services
- CCEL Managed Health Care
- Sector
- AGAE Telecommunications
- CCEL Health Care
- Exchange
- AGAE Nasdaq
- CCEL Nasdaq
- Market Cap
- AGAE 115.6M
- CCEL 39.9M
- IPO Year
- AGAE N/A
- CCEL 1997
- Fundamental
- Price
- AGAE $2.70
- CCEL $5.19
- Analyst Decision
- AGAE
- CCEL Strong Buy
- Analyst Count
- AGAE 0
- CCEL 1
- Target Price
- AGAE N/A
- CCEL $8.50
- AVG Volume (30 Days)
- AGAE 159.4K
- CCEL 14.7K
- Earning Date
- AGAE 08-18-2025
- CCEL 07-14-2025
- Dividend Yield
- AGAE N/A
- CCEL 19.49%
- EPS Growth
- AGAE N/A
- CCEL N/A
- EPS
- AGAE N/A
- CCEL 0.01
- Revenue
- AGAE $9,079,172.00
- CCEL $32,102,750.00
- Revenue This Year
- AGAE N/A
- CCEL $2.49
- Revenue Next Year
- AGAE N/A
- CCEL $0.95
- P/E Ratio
- AGAE N/A
- CCEL $568.17
- Revenue Growth
- AGAE 18.60
- CCEL 2.33
- 52 Week Low
- AGAE $0.70
- CCEL $4.75
- 52 Week High
- AGAE $3.79
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- AGAE 54.78
- CCEL 51.22
- Support Level
- AGAE $2.91
- CCEL $5.00
- Resistance Level
- AGAE $3.20
- CCEL $6.35
- Average True Range (ATR)
- AGAE 0.38
- CCEL 0.31
- MACD
- AGAE -0.04
- CCEL 0.02
- Stochastic Oscillator
- AGAE 41.20
- CCEL 14.07
About AGAE Allied Gaming & Entertainment Inc.
Allied Gaming & Entertainment Inc is an experiential entertainment company focused on providing a growing world of gamers with various experiences through renowned assets, products, and services.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.